Item Type | Name |
Academic Article
|
Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals.
|
Academic Article
|
Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.
|
Academic Article
|
Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16.
|
Academic Article
|
Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms.
|
Academic Article
|
Hookworm: "the great infection of mankind".
|
Academic Article
|
The impact of concurrent and treated Ancylostoma ceylanicum hookworm infections on the immunogenicity of a recombinant hookworm vaccine in hamsters.
|
Academic Article
|
Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects.
|
Academic Article
|
The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.
|
Academic Article
|
New technologies for the control of human hookworm infection.
|
Academic Article
|
Immunogenicity of the hookworm Na-ASP-2 vaccine candidate: characterization of humoral and cellular responses after vaccination in the Sprague Dawley rat.
|
Academic Article
|
An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection.
|
Academic Article
|
Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus.
|
Academic Article
|
Potency testing for the experimental Na-GST-1 hookworm vaccine.
|
Academic Article
|
Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.
|
Academic Article
|
Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.
|
Academic Article
|
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials.
|
Academic Article
|
An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases.
|
Academic Article
|
Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.
|
Academic Article
|
Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies.
|
Academic Article
|
The Human Hookworm Vaccine.
|
Academic Article
|
Innovation for the 'bottom 100 million': eliminating neglected tropical diseases in the Americas.
|
Concept
|
Vaccines, Inactivated
|
Concept
|
Vaccines
|
Concept
|
Vaccines, DNA
|
Concept
|
Protozoan Vaccines
|
Concept
|
Malaria Vaccines
|
Concept
|
Viral Vaccines
|
Concept
|
Vaccines, Synthetic
|
Concept
|
Vaccines, Combined
|
Concept
|
Influenza Vaccines
|
Concept
|
Leishmaniasis Vaccines
|
Concept
|
Bacterial Vaccines
|
Concept
|
Lyme Disease Vaccines
|
Concept
|
Vaccines, Subunit
|
Concept
|
Hepatitis B Vaccines
|
Academic Article
|
New vaccines for neglected parasitic diseases and dengue.
|
Academic Article
|
Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections.
|
Academic Article
|
Vaccines against neglected tropical diseases: promising interventions to rescue the poorest populations in the Americas.
|
Academic Article
|
Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis.
|
Academic Article
|
Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: a vaccine candidate for human intestinal schistosomiasis.
|
Academic Article
|
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.
|
Academic Article
|
Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model.
|
Academic Article
|
Calling for rapid development of a safe and effective MERS vaccine.
|
Academic Article
|
Limited antigenic variation in the Trypanosoma cruzi candidate vaccine antigen TSA-1.
|
Academic Article
|
Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate.
|
Academic Article
|
New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.
|
Academic Article
|
Bridging the innovation gap for neglected tropical diseases in Mexico: Capacity building for the development of a new generation of antipoverty vaccines. B
|
Academic Article
|
Parasitic Helminths. 1st Edition ed. Caffrey CR, editor. Weinheim, Germany: Wiley-Blackwell
|
Academic Article
|
New Generation Vaccines. 4th ed. Levine MM, editor. New York: Informa Helathcare USA
|
Academic Article
|
The human hookworm vaccine: recent updates and prospects for success.
|
Academic Article
|
Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine.
|
Academic Article
|
Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
|
Academic Article
|
New Vaccines for the World's Poorest People.
|
Academic Article
|
Human anthelminthic vaccines: Rationale and challenges.
|
Academic Article
|
Advancing a vaccine to prevent hookworm disease and anemia.
|
Academic Article
|
Advancing a vaccine to prevent human schistosomiasis.
|
Academic Article
|
Status of vaccine research and development of vaccines for Chagas disease.
|
Academic Article
|
Status of vaccine research and development of vaccines for leishmaniasis.
|
Academic Article
|
Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection.
|
Academic Article
|
A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
|
Academic Article
|
Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.
|
Academic Article
|
The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.
|
Academic Article
|
Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
|
Academic Article
|
Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis.
|
Academic Article
|
A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations.
|
Academic Article
|
Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine.
|
Academic Article
|
Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
|
Academic Article
|
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate.
|
Academic Article
|
Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis.
|
Academic Article
|
Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy.
|
Academic Article
|
Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response.
|
Academic Article
|
Onchocerca volvulus: The Road from Basic Biology to a Vaccine.
|
Academic Article
|
Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas Disease.
|
Academic Article
|
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.
|
Academic Article
|
Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
|
Academic Article
|
The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4+ T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway.
|
Academic Article
|
Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils.
|
Academic Article
|
Lessons along the Critical Path: Developing Vaccines against Human Helminths.
|
Academic Article
|
Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice.
|
Academic Article
|
IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against Infection.
|
Academic Article
|
Advancing the Development of a Human Schistosomiasis Vaccine.
|
Academic Article
|
Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients.
|
Academic Article
|
A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
|
Academic Article
|
"Running the Gauntlet": Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a "Call to Action".
|
Academic Article
|
A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
|
Academic Article
|
Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
|
Academic Article
|
Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens.
|
Academic Article
|
Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as?a Leishmania Vaccine Candidate.
|
Academic Article
|
The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
|
Academic Article
|
The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease.
|
Academic Article
|
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.
|
Academic Article
|
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement.
|
Academic Article
|
COVID-19 vaccine design: the Janus face of immune enhancement.
|
Academic Article
|
Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques.
|
Academic Article
|
COVID-19 vaccines: neutralizing antibodies and the alum advantage.
|
Academic Article
|
I Never Thought I Had "Moral Courage," until COVID-19 Happened.
|
Academic Article
|
Coronavirus vaccine-associated lung immunopathology-what is the significance?
|
Academic Article
|
Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis.
|
Academic Article
|
Developing a low-cost and accessible COVID-19 vaccine for global health.
|
Academic Article
|
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention.
|
Academic Article
|
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis.
|
Academic Article
|
Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial.
|
Academic Article
|
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
|
Academic Article
|
Preparing for SARS-CoV-2 Vaccines in US Immigrant Communities: Strategies for Allocation, Distribution, and Communication.
|
Academic Article
|
Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice.
|
Academic Article
|
Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection.
|
Academic Article
|
The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine.
|
Academic Article
|
Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members.
|
Academic Article
|
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate.
|
Academic Article
|
SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.
|
Academic Article
|
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1.
|
Academic Article
|
Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination.
|
Academic Article
|
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.
|
Academic Article
|
Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.
|
Academic Article
|
Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi.
|
Academic Article
|
Identification of vaccine targets in pathogens and design of a vaccine using computational approaches.
|
Academic Article
|
Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
|
Academic Article
|
Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon.
|
Academic Article
|
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines.
|
Academic Article
|
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate.
|
Academic Article
|
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.
|
Academic Article
|
ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection.
|
Academic Article
|
Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice.
|
Academic Article
|
Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study.
|
Academic Article
|
Vaxi-DL: A web-based deep learning server to identify potential vaccine candidates.
|
Academic Article
|
Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi.
|
Academic Article
|
Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine.
|
Academic Article
|
Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis.
|
Academic Article
|
Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights.
|
Academic Article
|
Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon.
|
Academic Article
|
Executive Summary: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba.
|
Academic Article
|
Full Technical Report: Insights from Cuba's COVID-19 Vaccine Enterprise: Report from a High Level Fact-Finding Delegation to Cuba.
|
Academic Article
|
Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease.
|
Academic Article
|
A Data-Driven Approach to Construct a Molecular Map of Trypanosoma cruzi to Identify Drugs and Vaccine Targets.
|
Academic Article
|
Human Schistosomiasis Vaccines as Next Generation Control Tools.
|
Academic Article
|
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area.
|
Academic Article
|
Vaccines and therapeutics for immunocompromised patients with COVID-19.
|
Academic Article
|
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access.
|
Academic Article
|
Vaxi-DL: An Artificial Intelligence-Enabled Platform for Vaccine Development.
|
Academic Article
|
Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis.
|
Academic Article
|
Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to Onchocerca volvulus in Mice and Non-Human Primates.
|
Academic Article
|
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2.
|
Academic Article
|
The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection.
|
Academic Article
|
Biophysical and biochemical characterization of a recombinant Lyme disease vaccine antigen, CspZ-YA.
|
Academic Article
|
Neglected tropical disease vaccines: hookworm, leishmaniasis, and schistosomiasis.
|
Academic Article
|
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease.
|
Academic Article
|
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.
|